Xiling Lab covers full chain of pharmaceutical industry with strong background and robust capabilities. We specialize in innovative XDC platform technology (especially linker-drug systems and conjugation technology) and highly complex generic products (oncology & contrast media, star products include Eribulin Mesylate Injection and APIs of Eribulin Mesylate, Lurbinectedin, Trabectedin, Gadobutrol, Deucravacitinib, Rimegepant Sulfate).
With our excellent synthetic process and unique catalytic technology, we not only have the capability for large-batch production but also ensure outstanding quality and effective cost control, which means we can offer more benefits to our partners.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 科园南路, 88号天府生命科技园,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Shanghai SIMR Biotech Co..
- HQ
- 成都市, 四川省
Xiling Lab Questions
Xiling Lab's website is http://www.xilinglab.com/en/index.aspx
Xiling Lab's LinkedIn profile is https://cn.linkedin.com/company/xiling-lab-2016
Xiling Lab has
4 employees.
View email and phone details for 4
employees at Xiling Lab.
Xiling Lab's industry is
Biotechnology Research
Xiling Lab's top competitors are
Primal Bee®,
Mafhoom Technologies Ltd,
Sustainable Planet,
Smartbreed Ag,
成都苑东生物制药股份有限公司/easton Biopharmaceutical Co.,ltd.,
Burger Index,
Param Labs Inc,
Sera Brynn,
Shanghai Simr Biotech Co.,ltd,
Geneditbio Limited.
Xiling Lab's categories are Biotechnology Research
Xiling Lab's founding year is 2016
